Edition:
United Kingdom

Peregrine Pharmaceuticals reports Q1 loss per share $0.06


Monday, 11 Sep 2017 

Sept 11 (Reuters) - Peregrine Pharmaceuticals Inc :Peregrine Pharmaceuticals reports financial results for first quarter of fiscal year 2018 and recent developments.Q1 loss per share $0.06.Sees Q2 2018 manufacturing revenue $50 million to $55 million.Peregrine Pharmaceuticals Inc - ‍Most of backlog is expected to be recognized during remainder of FY 2018​.Peregrine Pharmaceuticals Inc - " Avid bioservices current manufacturing revenue backlog is $33 million".Istar Inc - Company is providing manufacturing revenue guidance for full FY 2018 of $50 million - $55 million.FY2018 revenue view $56.0 million -- Thomson Reuters I/B/E/S. 

Company Quote

4.85
0.28 +6.13%
6:09pm BST